October 5-6, 2011
London
C5
C5’s 21st Forum on Biotech Patenting brings together eminent in-house counsel from the world’s largest pharma and biotech companies and their expert legal advisors from a range of European, U.S. and emerging market jurisdictions. Finnegan's Elizabeth Doherty will present “How to Navigate through Antibody Claims and Personalized Medicine/Biomarkers in the U.S.” The conference will be held at the Sheraton Park Lane Hotel in London, England. For more information, or to register, please see C5’s website.
Lecture
Patent Protection for Software-Related Inventions in Europe and the USA Training Course
June 5, 2024
Hybrid
Conference
Best Practices in Intellectual Property– A Decade of Dedication to IP Excellence
April 8-9, 2024
Tel Aviv
At the PTAB Blog
Federal Circuit PTAB Appeal Statistics for December 2023 and January 2024
March 8, 2024
At the PTAB Blog
IPR and PGR Statistics for Final Written Decisions Issued in January 2024
March 7, 2024
Federal Circuit IP Blog
Prior Printed Publications “Publicly Available” Despite Confidentiality Restrictions
March 7, 2024
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.